Biotech Losers: Dyax Corp. (NASDAQ:DYAX), Questcor Pharmaceuticals (NASDAQ:QCOR), Marina Biotech (OTCMKTS:MRNA), Celsus Therapeutics PLC (NASDAQ:CLTX)

Dyax Corp. (NASDAQ:DYAX) traded down 6.1% during trading on Thursday following insider selling activity, American Banking and Market News reports. The company traded as low as $9.65 and last traded at $10.16, with a volume of 1,411,366 shares. The stock had previously closed at $10.82. Dyax Corp. (NASDAQ:DYAX) stock opened at $10.28 in last session, and closed at $10.20, while the day range of stock is $9.65 – $10.47. The stock showed a positive weekly performance of 1.69%.

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) had its price target raised by analysts at Oppenheimer from $90.00 to $99.00. They now have an “outperform” rating on the stock. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stock opened at $73.48, in last session and closed at $67.47, by losing -9.08%. The 52 week range of the stock is $26.80 – $80.25. Company’s market capitalization is $4.08 billion.

Marina Biotech, Inc. (OTCMKTS:MRNA) is a stranger in a strange land right now- a biopharmaceutical company that sticks to its line of research, and has no chance of jumping over to become a medical marijuana company. MRNA is dealing with serious therapeutic opportunities based on RNA and its role in cellular function, and has recently risen in price, especially when it mentioned the new patent it received for its treatments. Marina Biotech, Inc. (OTCMKTS:MRNA) stock decreased -8.86% and finished the last session at $1.44. The EPS of the stock remained -2.62. Company’s market capitalization is $23.57 million.

Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) is a biopharmaceutical company. The Company is focused on the discovery and development of non-steroidal, synthetic anti-inflammatory drugs. The Company has two product candidates: MRX-4 and MRX-6. MRX-4 is a nasal spray for treating allergic rhinitis (or hay fever). MRX-6 is a topical cream for treating contact dermatitis (a common type of eczema). Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock opened the session at $6.78, and closed the session at $6.50. The 52 week range of the stock remained $6.06 – $25.00 and the day range was $6.21 – $6.95.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *